| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 1.08e-06 | 22 | 72 | 4 | GO:0004115 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 1.56e-06 | 24 | 72 | 4 | GO:0047555 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 1.86e-06 | 25 | 72 | 4 | GO:0004114 | |
| GeneOntologyMolecularFunction | cAMP binding | 1.86e-06 | 25 | 72 | 4 | GO:0030552 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 2.56e-06 | 27 | 72 | 4 | GO:0004112 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 3.94e-06 | 441 | 72 | 10 | GO:0016887 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 5.87e-06 | 33 | 72 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 1.16e-05 | 39 | 72 | 4 | GO:0030551 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNHD1 ABCB7 KIF15 ERCC6L ABCA13 CFTR NAIP TOR1A MACF1 ABCC9 DDX28 | 1.17e-05 | 614 | 72 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.91e-05 | 49 | 72 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 6.94e-05 | 193 | 72 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 7.77e-05 | 197 | 72 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 4.18e-04 | 97 | 72 | 4 | GO:0008081 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 4.45e-04 | 775 | 72 | 10 | GO:0017111 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 4.59e-04 | 178 | 72 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 5.66e-04 | 10 | 72 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 6.50e-04 | 109 | 72 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 8.22e-04 | 839 | 72 | 10 | GO:0016462 | |
| GeneOntologyMolecularFunction | Roundabout binding | 8.27e-04 | 12 | 72 | 2 | GO:0048495 | |
| GeneOntologyMolecularFunction | dynactin binding | 8.27e-04 | 12 | 72 | 2 | GO:0034452 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 8.30e-04 | 840 | 72 | 10 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 8.30e-04 | 840 | 72 | 10 | GO:0016818 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.29e-03 | 334 | 72 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | NAD+ nucleotidase, cyclic ADP-ribose generating | 1.49e-03 | 16 | 72 | 2 | GO:0061809 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.65e-03 | 140 | 72 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.89e-03 | 18 | 72 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.22e-03 | 152 | 72 | 4 | GO:0022843 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 2.80e-03 | 162 | 72 | 4 | GO:0099106 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 3.47e-03 | 172 | 72 | 4 | GO:0044325 | |
| GeneOntologyMolecularFunction | channel regulator activity | 3.61e-03 | 174 | 72 | 4 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 3.84e-03 | 177 | 72 | 4 | GO:0141108 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 4.24e-03 | 182 | 72 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 4.41e-03 | 184 | 72 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | tubulin binding | 4.44e-03 | 428 | 72 | 6 | GO:0015631 | |
| GeneOntologyMolecularFunction | calcium ion binding | 5.44e-03 | 749 | 72 | 8 | GO:0005509 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 5.57e-03 | 31 | 72 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | BICDL1 PDE4B KIF15 MAPT ABRAXAS1 SYNE1 TOR1A MACF1 RABGAP1 ACTN1 | 5.88e-03 | 1099 | 72 | 10 | GO:0008092 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 6.21e-03 | 459 | 72 | 6 | GO:0005216 | |
| GeneOntologyBiologicalProcess | cAMP catabolic process | 1.79e-08 | 9 | 73 | 4 | GO:0006198 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 2.43e-08 | 25 | 73 | 5 | GO:0046058 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide catabolic process | 1.41e-07 | 14 | 73 | 4 | GO:0009214 | |
| GeneOntologyBiologicalProcess | cyclic purine nucleotide metabolic process | 4.71e-07 | 44 | 73 | 5 | GO:0052652 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide metabolic process | 5.29e-07 | 45 | 73 | 5 | GO:0009187 | |
| GeneOntologyBiologicalProcess | cAMP-mediated signaling | 7.34e-06 | 76 | 73 | 5 | GO:0019933 | |
| GeneOntologyBiologicalProcess | negative regulation of relaxation of cardiac muscle | 1.24e-05 | 2 | 73 | 2 | GO:1901898 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell contraction | 1.61e-05 | 43 | 73 | 4 | GO:0086004 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.97e-05 | 93 | 73 | 5 | GO:0086003 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based movement | 3.71e-05 | 53 | 73 | 4 | GO:1903115 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic anion transport | 7.38e-05 | 4 | 73 | 2 | GO:1903793 | |
| GeneOntologyBiologicalProcess | muscle contraction | 8.34e-05 | 400 | 73 | 8 | GO:0006936 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 8.79e-05 | 127 | 73 | 5 | GO:0070252 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway | 1.04e-04 | 26 | 73 | 3 | GO:0106070 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.20e-04 | 217 | 73 | 6 | GO:0006941 | |
| GeneOntologyBiologicalProcess | response to organophosphorus | 1.49e-04 | 142 | 73 | 5 | GO:0046683 | |
| GeneOntologyBiologicalProcess | reactive oxygen species biosynthetic process | 1.86e-04 | 80 | 73 | 4 | GO:1903409 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.11e-04 | 153 | 73 | 5 | GO:0030048 | |
| GeneOntologyBiologicalProcess | negative regulation of relaxation of muscle | 2.56e-04 | 7 | 73 | 2 | GO:1901078 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 2.81e-04 | 89 | 73 | 4 | GO:0055117 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 3.07e-04 | 166 | 73 | 5 | GO:0014074 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 3.16e-04 | 167 | 73 | 5 | GO:0060048 | |
| GeneOntologyBiologicalProcess | regulation of relaxation of cardiac muscle | 4.38e-04 | 9 | 73 | 2 | GO:1901897 | |
| GeneOntologyBiologicalProcess | reactive oxygen species metabolic process | 5.77e-04 | 291 | 73 | 6 | GO:0072593 | |
| GeneOntologyBiologicalProcess | regulation of establishment of protein localization | 6.05e-04 | 674 | 73 | 9 | GO:0070201 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | ADCY10 PDE4A PDE4B PDE4C PDE4D HCN4 ASGR2 SYNE1 CNTRL TLR4 PREX1 RYR1 | 7.63e-05 | 934 | 72 | 12 | GO:0048471 |
| GeneOntologyCellularComponent | membrane attack complex | 2.43e-04 | 7 | 72 | 2 | GO:0005579 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 3.21e-04 | 378 | 72 | 7 | GO:0034702 | |
| GeneOntologyCellularComponent | myofibril | 3.57e-04 | 273 | 72 | 6 | GO:0030016 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 4.27e-04 | 523 | 72 | 8 | GO:1902495 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 4.91e-04 | 290 | 72 | 6 | GO:0043292 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 5.35e-04 | 46 | 72 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | transporter complex | 5.96e-04 | 550 | 72 | 8 | GO:1990351 | |
| GeneOntologyCellularComponent | somatodendritic compartment | ADCY10 GABRD PDE4B SNCAIP HCN4 MAPT SYNE1 CFTR NAIP RTN4RL1 ACTN1 PREX1 | 9.29e-04 | 1228 | 72 | 12 | GO:0036477 |
| GeneOntologyCellularComponent | centrosome | 1.27e-03 | 770 | 72 | 9 | GO:0005813 | |
| GeneOntologyCellularComponent | cation channel complex | 1.31e-03 | 235 | 72 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | sarcomere | 1.68e-03 | 249 | 72 | 5 | GO:0030017 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.05e-03 | 73 | 72 | 3 | GO:0034704 | |
| MousePheno | impaired neutrophil chemotaxis | 2.03e-05 | 40 | 57 | 4 | MP:0008720 | |
| Domain | PDEase | 7.12e-07 | 19 | 71 | 4 | IPR023088 | |
| Domain | PDEase_I | 1.09e-06 | 21 | 71 | 4 | PF00233 | |
| Domain | PDEASE_I | 1.09e-06 | 21 | 71 | 4 | PS00126 | |
| Domain | PDEase_CS | 1.09e-06 | 21 | 71 | 4 | IPR023174 | |
| Domain | Cys-rich_flank_reg_C | 1.18e-06 | 90 | 71 | 6 | IPR000483 | |
| Domain | LRRCT | 1.18e-06 | 90 | 71 | 6 | SM00082 | |
| Domain | - | 1.33e-06 | 22 | 71 | 4 | 1.10.1300.10 | |
| Domain | PDEase_catalytic_dom | 1.61e-06 | 23 | 71 | 4 | IPR002073 | |
| Domain | HDc | 1.92e-06 | 24 | 71 | 4 | SM00471 | |
| Domain | HD/PDEase_dom | 1.92e-06 | 24 | 71 | 4 | IPR003607 | |
| Domain | - | 3.42e-06 | 321 | 71 | 9 | 3.80.10.10 | |
| Domain | L_dom-like | 4.07e-06 | 328 | 71 | 9 | IPR032675 | |
| Domain | Leu-rich_rpt_typical-subtyp | 4.86e-06 | 177 | 71 | 7 | IPR003591 | |
| Domain | LRR_TYP | 4.86e-06 | 177 | 71 | 7 | SM00369 | |
| Domain | Leu-rich_rpt | 8.55e-06 | 271 | 71 | 8 | IPR001611 | |
| Domain | LRR | 1.12e-05 | 201 | 71 | 7 | PS51450 | |
| Domain | LRR_1 | 1.95e-05 | 219 | 71 | 7 | PF00560 | |
| Domain | ABC_tran | 3.29e-05 | 48 | 71 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 3.29e-05 | 48 | 71 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 3.57e-05 | 49 | 71 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 3.87e-05 | 50 | 71 | 4 | IPR003439 | |
| Domain | LRR_8 | 4.72e-05 | 171 | 71 | 6 | PF13855 | |
| Domain | P-loop_NTPase | ADCY10 DNHD1 ABCB7 KIF15 ERCC6L ABCA13 CFTR NAIP TOR1A ABCC9 DDX28 NLRP13 | 7.68e-05 | 848 | 71 | 12 | IPR027417 |
| Domain | FOXP-CC | 8.51e-05 | 4 | 71 | 2 | PF16159 | |
| Domain | FOXP-CC | 8.51e-05 | 4 | 71 | 2 | IPR032354 | |
| Domain | Actinin_actin-bd_CS | 8.83e-05 | 23 | 71 | 3 | IPR001589 | |
| Domain | Spectrin | 8.83e-05 | 23 | 71 | 3 | PF00435 | |
| Domain | ACTININ_2 | 8.83e-05 | 23 | 71 | 3 | PS00020 | |
| Domain | ACTININ_1 | 8.83e-05 | 23 | 71 | 3 | PS00019 | |
| Domain | ABC_membrane | 1.01e-04 | 24 | 71 | 3 | PF00664 | |
| Domain | - | ADCY10 DNHD1 ABCB7 ERCC6L ABCA13 CFTR NAIP TOR1A ABCC9 DDX28 NLRP13 | 1.10e-04 | 746 | 71 | 11 | 3.40.50.300 |
| Domain | Toll-like_receptor | 1.41e-04 | 5 | 71 | 2 | IPR017241 | |
| Domain | ABC_TM1F | 1.61e-04 | 28 | 71 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 1.61e-04 | 28 | 71 | 3 | IPR011527 | |
| Domain | Spectrin_repeat | 1.79e-04 | 29 | 71 | 3 | IPR002017 | |
| Domain | AAA+_ATPase | 2.20e-04 | 144 | 71 | 5 | IPR003593 | |
| Domain | AAA | 2.20e-04 | 144 | 71 | 5 | SM00382 | |
| Domain | Spectrin/alpha-actinin | 2.41e-04 | 32 | 71 | 3 | IPR018159 | |
| Domain | SPEC | 2.41e-04 | 32 | 71 | 3 | SM00150 | |
| Domain | EF_hand_dom | 2.51e-04 | 232 | 71 | 6 | IPR002048 | |
| Domain | EF-hand_1 | 2.82e-04 | 152 | 71 | 5 | PF00036 | |
| Domain | - | 4.71e-04 | 261 | 71 | 6 | 1.10.238.10 | |
| Domain | LRRNT | 5.29e-04 | 98 | 71 | 4 | IPR000372 | |
| Domain | LRRNT | 5.29e-04 | 98 | 71 | 4 | SM00013 | |
| Domain | EF_Hand_1_Ca_BS | 5.39e-04 | 175 | 71 | 5 | IPR018247 | |
| Domain | ABC_transporter_CS | 5.43e-04 | 42 | 71 | 3 | IPR017871 | |
| Domain | EF-hand-dom_pair | 7.75e-04 | 287 | 71 | 6 | IPR011992 | |
| Domain | EF_HAND_1 | 1.07e-03 | 204 | 71 | 5 | PS00018 | |
| Domain | EF_HAND_2 | 1.86e-03 | 231 | 71 | 5 | PS50222 | |
| Domain | CH | 1.94e-03 | 65 | 71 | 3 | SM00033 | |
| Domain | CH | 2.40e-03 | 70 | 71 | 3 | PF00307 | |
| Domain | - | 2.50e-03 | 71 | 71 | 3 | 1.10.418.10 | |
| Domain | CH | 2.71e-03 | 73 | 71 | 3 | PS50021 | |
| Domain | TIR | 2.86e-03 | 21 | 71 | 2 | SM00255 | |
| Domain | CH-domain | 2.92e-03 | 75 | 71 | 3 | IPR001715 | |
| Domain | EFh | 3.09e-03 | 158 | 71 | 4 | SM00054 | |
| Domain | TIR | 3.13e-03 | 22 | 71 | 2 | PF01582 | |
| Domain | NACHT | 3.42e-03 | 23 | 71 | 2 | PS50837 | |
| Domain | NACHT_NTPase | 3.42e-03 | 23 | 71 | 2 | IPR007111 | |
| Domain | - | 3.42e-03 | 23 | 71 | 2 | 3.40.50.10140 | |
| Domain | TIR | 3.73e-03 | 24 | 71 | 2 | PS50104 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 3.38e-07 | 16 | 54 | 4 | MM14699 | |
| Pathway | WP_SILDENAFIL_TREATMENT | 1.61e-06 | 23 | 54 | 4 | M46455 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 1.93e-06 | 24 | 54 | 4 | M751 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 2.05e-06 | 55 | 54 | 5 | M39763 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 2.33e-05 | 44 | 54 | 4 | M11911 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.54e-04 | 71 | 54 | 4 | MM14491 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION | 2.99e-04 | 7 | 54 | 2 | M47873 | |
| Pathway | KEGG_PURINE_METABOLISM | 3.47e-04 | 159 | 54 | 5 | M14314 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 3.85e-04 | 90 | 54 | 4 | M6467 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 3.85e-04 | 90 | 54 | 4 | MM15882 | |
| Pathway | BIOCARTA_ALTERNATIVE_PATHWAY | 3.97e-04 | 8 | 54 | 2 | MM1582 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 3.97e-04 | 8 | 54 | 2 | M27006 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 3.97e-04 | 8 | 54 | 2 | MM14656 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 4.02e-04 | 91 | 54 | 4 | M39426 | |
| Pathway | WP_PURINE_METABOLISM | 4.85e-04 | 171 | 54 | 5 | MM15909 | |
| Pathway | BIOCARTA_ALTERNATIVE_PATHWAY | 5.10e-04 | 9 | 54 | 2 | M22072 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 7.75e-04 | 11 | 54 | 2 | MM1430 | |
| Pathway | WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY | 9.27e-04 | 12 | 54 | 2 | M48316 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 9.27e-04 | 12 | 54 | 2 | MM1368 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.09e-03 | 13 | 54 | 2 | M4732 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.46e-03 | 15 | 54 | 2 | M7146 | |
| Pathway | WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE | 1.89e-03 | 17 | 54 | 2 | M39733 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 1.89e-03 | 17 | 54 | 2 | MM15944 | |
| Pathway | BIOCARTA_LAIR_PATHWAY | 1.89e-03 | 17 | 54 | 2 | M3952 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 1.89e-03 | 17 | 54 | 2 | MM1369 | |
| Pathway | WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY | 2.12e-03 | 18 | 54 | 2 | M39478 | |
| Pubmed | 3.54e-14 | 5 | 73 | 5 | 33944911 | ||
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 9371714 | ||
| Pubmed | Assessment of PDE4 Inhibitor-Induced Hypothermia as a Correlate of Nausea in Mice. | 1.79e-11 | 4 | 73 | 4 | 34943270 | |
| Pubmed | PAN-selective inhibition of cAMP-phosphodiesterase 4 (PDE4) induces gastroparesis in mice. | 1.79e-11 | 4 | 73 | 4 | 32738081 | |
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 8413254 | ||
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 22946044 | ||
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 33609559 | ||
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 24732776 | ||
| Pubmed | 8.91e-11 | 5 | 73 | 4 | 8586960 | ||
| Pubmed | Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. | 2.67e-10 | 6 | 73 | 4 | 18923023 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 24555506 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 17404263 | ||
| Pubmed | Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages. | 8.87e-09 | 3 | 73 | 3 | 16034090 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 15585880 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 10213096 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 18508768 | ||
| Pubmed | Chromosome localizations of genes for five cAMP-specific phosphodiesterases in man and mouse. | 1.26e-08 | 13 | 73 | 4 | 8009369 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 21670503 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 15644445 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 11839681 | ||
| Pubmed | Interaction between LIS1 and PDE4, and its role in cytoplasmic dynein function. | 8.84e-08 | 5 | 73 | 3 | 21652625 | |
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 28383060 | ||
| Pubmed | 2.18e-07 | 25 | 73 | 4 | 17307970 | ||
| Pubmed | 4.93e-07 | 8 | 73 | 3 | 17536017 | ||
| Pubmed | 3.18e-06 | 14 | 73 | 3 | 25852085 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 2808363 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 31324945 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 21344240 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 28235598 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 18209474 | ||
| Pubmed | TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells. | 4.35e-06 | 2 | 73 | 2 | 19502387 | |
| Pubmed | PDE4D and PDE4B function in distinct subcellular compartments in mouse embryonic fibroblasts. | 4.35e-06 | 2 | 73 | 2 | 21288894 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 9520403 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 35960843 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17727341 | ||
| Pubmed | Atropine augments cardiac contractility by inhibiting cAMP-specific phosphodiesterase type 4. | 4.35e-06 | 2 | 73 | 2 | 29123207 | |
| Pubmed | Calnuc binds to Alzheimer's beta-amyloid precursor protein and affects its biogenesis. | 4.35e-06 | 2 | 73 | 2 | 17348862 | |
| Pubmed | Modulation of nucleobindin-1 and nucleobindin-2 by caspases. | 4.35e-06 | 2 | 73 | 2 | 18154733 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 21047676 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 21653697 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 21593379 | ||
| Pubmed | Association of specific language impairment (SLI) to the region of 7q31. | 4.35e-06 | 2 | 73 | 2 | 12721956 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 23043089 | ||
| Pubmed | C5a and toll-like receptor 4 crosstalk in retinal pigment epithelial cells. | 4.35e-06 | 2 | 73 | 2 | 26487798 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 15003452 | ||
| Pubmed | PDE4D plays a critical role in the control of airway smooth muscle contraction. | 4.35e-06 | 2 | 73 | 2 | 14519662 | |
| Pubmed | Toll-like receptor-4 genotype influences the survival of cystic fibrosis mice. | 4.35e-06 | 2 | 73 | 2 | 20522639 | |
| Pubmed | Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B). | 4.35e-06 | 2 | 73 | 2 | 17700644 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 37643860 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17088426 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 11267656 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 22500023 | ||
| Pubmed | Modifier effect of the Toll-like receptor 4 D299G polymorphism in children with cystic fibrosis. | 4.35e-06 | 2 | 73 | 2 | 16830219 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 21712022 | ||
| Pubmed | 4.87e-06 | 16 | 73 | 3 | 28283561 | ||
| Pubmed | 9.24e-06 | 493 | 73 | 8 | 15368895 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FOXP4 PDE4D LRRN1 MAPT CDK13 NUCB2 AGPAT3 NAIP RTN4RL1 MACF1 RABGAP1 UQCRC1 PRDM15 | 1.21e-05 | 1489 | 73 | 13 | 28611215 |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 27624101 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 14516685 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 28356347 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 15731086 | ||
| Pubmed | Human-specific transcriptional regulation of CNS development genes by FOXP2. | 1.30e-05 | 3 | 73 | 2 | 19907493 | |
| Pubmed | TLR2, TLR4 and TLR10 Shape the Cytokine and Chemokine Release of H. pylori-Infected Human DCs. | 1.30e-05 | 3 | 73 | 2 | 32486097 | |
| Pubmed | Ezrin links CFTR to TLR4 signaling to orchestrate anti-bacterial immune response in macrophages. | 1.30e-05 | 3 | 73 | 2 | 28883468 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 11114167 | ||
| Pubmed | TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins. | 1.30e-05 | 3 | 73 | 2 | 24445575 | |
| Pubmed | Transcriptional regulation by FOXP1, FOXP2, and FOXP4 dimerization. | 1.30e-05 | 3 | 73 | 2 | 25027557 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 25999468 | ||
| Pubmed | Formation and structure of the C5b-7 complex of the lytic pathway of complement. | 1.30e-05 | 3 | 73 | 2 | 1387399 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 34420402 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 28507505 | ||
| Pubmed | 2.50e-05 | 27 | 73 | 3 | 11156964 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 14701752 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 29057902 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 25735751 | ||
| Pubmed | Identification and characterization of T reg-like cells in zebrafish. | 2.60e-05 | 4 | 73 | 2 | 29066577 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 22314397 | ||
| Pubmed | mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. | 2.60e-05 | 4 | 73 | 2 | 11296225 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 29566186 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 22491257 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 16365047 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 23008439 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 18268335 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 25239913 | ||
| Pubmed | Identification of an essential spinoparabrachial pathway for mechanical itch. | 4.33e-05 | 5 | 73 | 2 | 37023756 | |
| Pubmed | Predominant role for C5b-9 in renal ischemia/reperfusion injury. | 4.33e-05 | 5 | 73 | 2 | 10811844 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 20196770 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 22703024 | ||
| Pubmed | A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. | 4.33e-05 | 5 | 73 | 2 | 19029192 | |
| Pubmed | Analyses of associations with asthma in four asthma population samples from Canada and Australia. | 4.34e-05 | 92 | 73 | 4 | 19247692 | |
| Pubmed | New genetic associations detected in a host response study to hepatitis B vaccine. | 5.64e-05 | 824 | 73 | 9 | 20237496 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 17619227 | ||
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 15728506 | ||
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 18827015 | ||
| Pubmed | Structural and functional understanding of the toll-like receptors. | 6.48e-05 | 6 | 73 | 2 | 33576548 | |
| Pubmed | Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9. | 6.48e-05 | 6 | 73 | 2 | 22832194 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 28591638 | ||
| Pubmed | 6.75e-05 | 103 | 73 | 4 | 10574462 | ||
| Pubmed | Chromatin Remodeling BAF155 Subunit Regulates the Genesis of Basal Progenitors in Developing Cortex. | 7.10e-05 | 38 | 73 | 3 | 30240734 | |
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 18983980 | ||
| Interaction | AKAP6 interactions | 3.44e-07 | 17 | 72 | 4 | int:AKAP6 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q33 | 7.24e-05 | 138 | 73 | 4 | chr9q33 | |
| GeneFamily | Phosphodiesterases | 7.78e-07 | 24 | 55 | 4 | 681 | |
| GeneFamily | CD molecules|Toll like receptors | 4.03e-04 | 10 | 55 | 2 | 948 | |
| GeneFamily | ATP binding cassette subfamily C | 6.94e-04 | 13 | 55 | 2 | 807 | |
| GeneFamily | NLR family | 2.61e-03 | 25 | 55 | 2 | 666 | |
| GeneFamily | EF-hand domain containing | 4.41e-03 | 219 | 55 | 4 | 863 | |
| GeneFamily | Complement system|Sushi domain containing | 5.36e-03 | 36 | 55 | 2 | 492 | |
| Coexpression | GSE3982_MAST_CELL_VS_BCELL_DN | 1.73e-05 | 197 | 72 | 6 | M5437 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | MYOF PDE4B PDE4D SNCAIP FOXP2 MAPT ITSN2 TLR4 KANK4 RTN4RL1 MACF1 | 2.03e-05 | 854 | 72 | 11 | M1533 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | MYOF PDE4B PDE4D SNCAIP FOXP2 MAPT ITSN2 TLR4 KANK4 RTN4RL1 MACF1 | 2.90e-05 | 888 | 72 | 11 | MM1018 |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.15e-07 | 176 | 72 | 6 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 8.76e-07 | 200 | 72 | 6 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 8.76e-07 | 200 | 72 | 6 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-06 | 172 | 72 | 5 | f814b6134ad608015765399d54cc1e5e1873ed34 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.35e-05 | 188 | 72 | 5 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-05 | 190 | 72 | 5 | 106862ef44fcaa0971c3ba0147d13eb08015ca77 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 192 | 72 | 5 | 430ef714bf2544d32f3fd96a55af010f79aa9be0 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-05 | 192 | 72 | 5 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.53e-05 | 193 | 72 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.53e-05 | 193 | 72 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.53e-05 | 193 | 72 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.65e-05 | 196 | 72 | 5 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.65e-05 | 196 | 72 | 5 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.69e-05 | 197 | 72 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-05 | 197 | 72 | 5 | c7b33d64e5cba3a8fc6f2d6aa85ebc83893195de | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 197 | 72 | 5 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.73e-05 | 198 | 72 | 5 | d087e738d69ca9853553fde46d4e7a8906439d32 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 1.73e-05 | 198 | 72 | 5 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.77e-05 | 199 | 72 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-05 | 199 | 72 | 5 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Sigmoid-(5)_Dendritic_cell-(51)_cDC1|Sigmoid / shred on region, Cell_type, and subtype | 1.81e-05 | 200 | 72 | 5 | 4ce0a2238c90622e41fd86ac4b7d82adf4af2c3b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 200 | 72 | 5 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 200 | 72 | 5 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 200 | 72 | 5 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 200 | 72 | 5 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 200 | 72 | 5 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 200 | 72 | 5 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | Sigmoid-Dendritic_cell-cDC1|Sigmoid / Region, Cell class and subclass | 1.81e-05 | 200 | 72 | 5 | 3523ec986e8c9e176e08836c974b1de8b56d8b16 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 200 | 72 | 5 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 200 | 72 | 5 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 200 | 72 | 5 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 200 | 72 | 5 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.05e-05 | 125 | 72 | 4 | 2938a1d62afe1e0a3abba5eb92f07b886cc0accd | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.88e-05 | 130 | 72 | 4 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_E|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.81e-05 | 135 | 72 | 4 | 35928195cf34f055b353562c96f451aef2344d64 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 6.81e-05 | 135 | 72 | 4 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | TCGA-Bile_Duct|World / Sample_Type by Project: Shred V9 | 7.84e-05 | 140 | 72 | 4 | ca8a0ccbc2f501b759864fe9bb06dc8b44b6b31f | |
| ToppCell | AT1-AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.16e-04 | 155 | 72 | 4 | 010e45ef4b505bf419ea41e4d1619521d1c78319 | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epi_progenitor|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.28e-04 | 159 | 72 | 4 | a4bfd59c53237964fc24a24de5c1925fdd01db99 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-CMP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.31e-04 | 160 | 72 | 4 | be46daf3b42591768c83062a3bb4820efbf88bec | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.38e-04 | 162 | 72 | 4 | 19395bdb282b4a2d88cd33191af12c24a88c3d16 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 162 | 72 | 4 | 8e0f03fcc25b2ea777e8478fbf771699cf93719c | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 162 | 72 | 4 | e0417f1242edf71934fe62bccc55c4678f7ff4ac | |
| ToppCell | Dendritic_Cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.51e-04 | 166 | 72 | 4 | fbeb74b98b58085de323f744b18d4a8f7b22d5d4 | |
| ToppCell | P07-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.51e-04 | 166 | 72 | 4 | 021b9344de7957762f81b09a647504b8c8289cf1 | |
| ToppCell | (0)_Myeloid-(00)_Monocyte-(000)_CD14+_Monocyte|(00)_Monocyte / immune cells in Peripheral Blood (logTPM normalization) | 1.55e-04 | 167 | 72 | 4 | 7d9fd6a7a45c2aa0d5f2e3960ca4c97ee8836ba5 | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-Progen-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.55e-04 | 167 | 72 | 4 | b89ebd4906f52b1fe6b6540ec9339284e7caddd2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 169 | 72 | 4 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 1.62e-04 | 169 | 72 | 4 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.62e-04 | 169 | 72 | 4 | ec23caecbb0d969307e33e9df8499ddcd1420305 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.62e-04 | 169 | 72 | 4 | 53e863de064d44e1d36e21fb3dbba37ae020f6e9 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epi_progenitor|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.62e-04 | 169 | 72 | 4 | 1a47a4892a5e6a69555f5332308503526e5422a7 | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.66e-04 | 170 | 72 | 4 | 6c0619cbe2f01a6de18da0a137f92bda0cbdf075 | |
| ToppCell | P03-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.66e-04 | 170 | 72 | 4 | 3fd37e9b377d6485cea1262c31a8507d18a78514 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 170 | 72 | 4 | 4848965bc7e9356c6601bb41eeea1553d2eea87e | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 171 | 72 | 4 | d1e87478d8c0329e662849823f5c7604f20e1b1a | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 171 | 72 | 4 | 95e87987a2332fa646849fb0de785f1e0b8a07dd | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.69e-04 | 171 | 72 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 171 | 72 | 4 | 36657e277aad75c4f157c1726c48e09b5836cf37 | |
| ToppCell | COVID-19_Mild-PLT_2|COVID-19_Mild / Disease Group and Platelet Clusters | 1.77e-04 | 173 | 72 | 4 | d11705e56b6b21eec963ea224717f27680c781ed | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-04 | 173 | 72 | 4 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.77e-04 | 173 | 72 | 4 | b6bb2a136a40f0946bbcde8d5972d3f059d080c7 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-04 | 173 | 72 | 4 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.81e-04 | 174 | 72 | 4 | 23c7fdfc73170cfc5cdee5bb7fbee0c8bbbbca07 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.83e-04 | 68 | 72 | 3 | f1cbc6d72489272c1eb6200f64b8b6444719acda | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-04 | 175 | 72 | 4 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.85e-04 | 175 | 72 | 4 | a6d9ca35d3c4b4e3889d0a69b514f63ae630da6b | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.89e-04 | 176 | 72 | 4 | ac76f2cd6c63f30b38b89b58bad2baa4dde8ce3a | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-04 | 178 | 72 | 4 | 0fb36679cddc9ed8f4b5b34e174d5133c2ea1c76 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-04 | 179 | 72 | 4 | d15182c668d7c37be8214cad9f1fe35d1409c9a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-04 | 179 | 72 | 4 | e22a275a7c0ed19113c833a75d6c49fcc19aa13a | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 2.02e-04 | 179 | 72 | 4 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.06e-04 | 180 | 72 | 4 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.06e-04 | 180 | 72 | 4 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | control-Lymphoid-B_cell|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.11e-04 | 181 | 72 | 4 | e414303bb90e5fe7b667c2acf9a50f8694b90e54 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 181 | 72 | 4 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 182 | 72 | 4 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.15e-04 | 182 | 72 | 4 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 182 | 72 | 4 | ffe500d78a89dc6b4d05bab1664e7f30c94fb8d9 | |
| ToppCell | NS-control-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.15e-04 | 182 | 72 | 4 | 4b9b55154a79992112c1c467e8752c3cdbb541d9 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 182 | 72 | 4 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 182 | 72 | 4 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.20e-04 | 183 | 72 | 4 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 2.20e-04 | 183 | 72 | 4 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 183 | 72 | 4 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 184 | 72 | 4 | 94748f63947db79a6b4540e3090a63689fdd9452 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 184 | 72 | 4 | 819b277ecced7b415e363c7e7ddbc6f3b2d296de | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.24e-04 | 184 | 72 | 4 | 33db879e629821fb75684e60f8f0749cf9623bdd | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-04 | 184 | 72 | 4 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-04 | 184 | 72 | 4 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-04 | 184 | 72 | 4 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.29e-04 | 185 | 72 | 4 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.34e-04 | 186 | 72 | 4 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.34e-04 | 186 | 72 | 4 | 7c1807fca590cdccf7f5734460bac228d33964ca | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-04 | 186 | 72 | 4 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 187 | 72 | 4 | dba4924d914a7dcd4901142684ba920c2404860b | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 187 | 72 | 4 | 9688141beef4f62613d7a810c5872ccb9afc1a71 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 2.38e-04 | 187 | 72 | 4 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 187 | 72 | 4 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.38e-04 | 187 | 72 | 4 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| Drug | trequinsin | 3.43e-11 | 9 | 72 | 5 | ctd:C035964 | |
| Drug | L-826,141 | 3.43e-11 | 9 | 72 | 5 | ctd:C459562 | |
| Drug | Piclamilast | 9.19e-11 | 4 | 72 | 4 | DB01791 | |
| Drug | Ibudilast | 4.58e-10 | 5 | 72 | 4 | DB05266 | |
| Drug | 1,7-naphthyridine | 4.58e-10 | 5 | 72 | 4 | CID000009209 | |
| Drug | Iloprost | 3.19e-09 | 7 | 72 | 4 | DB01088 | |
| Drug | Ketotifen | 3.19e-09 | 7 | 72 | 4 | DB00920 | |
| Drug | Dyphylline | 6.37e-09 | 8 | 72 | 4 | DB00651 | |
| Drug | NVP ABE171 | 1.90e-08 | 10 | 72 | 4 | ctd:C451724 | |
| Drug | 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid | 3.03e-08 | 3 | 72 | 3 | DB08299 | |
| Drug | Roflumilast | 1.63e-07 | 16 | 72 | 4 | ctd:C424423 | |
| Drug | Cilomilast | 2.72e-07 | 18 | 72 | 4 | ctd:C433247 | |
| Drug | D-22888 | 3.02e-07 | 5 | 72 | 3 | CID000197714 | |
| Drug | AA-2379 | 5.28e-07 | 21 | 72 | 4 | CID000128390 | |
| Drug | HWA 153 | 6.44e-07 | 22 | 72 | 4 | CID000162797 | |
| Drug | atherosperminine | 7.78e-07 | 23 | 72 | 4 | CID000096918 | |
| Drug | griseolic acid | 7.78e-07 | 23 | 72 | 4 | CID000127607 | |
| Drug | felodipine | 1.08e-06 | 169 | 72 | 7 | CID000003333 | |
| Drug | Ro 15-2041 | 1.30e-06 | 26 | 72 | 4 | CID000132434 | |
| Drug | desethyl KBT-3022 | 1.30e-06 | 26 | 72 | 4 | CID000127736 | |
| Drug | T-440 | 1.30e-06 | 26 | 72 | 4 | CID000177965 | |
| Drug | papaverine | 1.41e-06 | 176 | 72 | 7 | CID000004680 | |
| Drug | KF18280 | 1.68e-06 | 8 | 72 | 3 | CID003071941 | |
| Drug | canola oil | 2.45e-06 | 122 | 72 | 6 | ctd:C061996 | |
| Drug | imidazole-4-carboxamide | 3.09e-06 | 32 | 72 | 4 | CID000152917 | |
| Drug | dyphylline | 3.51e-06 | 33 | 72 | 4 | CID000003182 | |
| Drug | AH 21-132 | 5.61e-06 | 37 | 72 | 4 | CID003035793 | |
| Drug | Rolipram | 5.61e-06 | 37 | 72 | 4 | ctd:D020889 | |
| Drug | milrinone | 8.08e-06 | 150 | 72 | 6 | CID000004197 | |
| Drug | M 98 | 9.86e-06 | 2 | 72 | 2 | CID006420180 | |
| Drug | V11294 Analogue 5f | 9.86e-06 | 2 | 72 | 2 | CID011214587 | |
| Drug | V11294 Analogue 5i | 9.86e-06 | 2 | 72 | 2 | CID011376249 | |
| Drug | V11294 Analogue 5t | 9.86e-06 | 2 | 72 | 2 | CID011226695 | |
| Drug | V11294 Analogue 5e | 9.86e-06 | 2 | 72 | 2 | CID011443441 | |
| Drug | V11294 Analogue 5d | 9.86e-06 | 2 | 72 | 2 | CID011283750 | |
| Drug | V11294 Analogue 5n | 9.86e-06 | 2 | 72 | 2 | CID011238279 | |
| Drug | 3-cyclopentyloxy-4-methoxybenzoic acid | 9.86e-06 | 2 | 72 | 2 | CID002779323 | |
| Drug | V11294 Analogue 5v | 9.86e-06 | 2 | 72 | 2 | CID011375325 | |
| Drug | V11294 Analogue 5p | 9.86e-06 | 2 | 72 | 2 | CID011478659 | |
| Drug | 3-cyclopentyloxy-4-methoxybenzaldehyde | 9.86e-06 | 2 | 72 | 2 | CID002735893 | |
| Drug | V11294 Analogue 5o | 9.86e-06 | 2 | 72 | 2 | CID011249748 | |
| Drug | V11294 Analogue 5c | 9.86e-06 | 2 | 72 | 2 | CID011179896 | |
| Drug | V11294 Analogue 5b | 9.86e-06 | 2 | 72 | 2 | CID011443760 | |
| Drug | Cis-4-Cyano-4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]Cyclohexanecarboxylic Acid | 9.86e-06 | 2 | 72 | 2 | DB03849 | |
| Drug | T-2585.HCl | 9.86e-06 | 2 | 72 | 2 | CID006918355 | |
| Drug | Np-V | 9.86e-06 | 2 | 72 | 2 | CID009999276 | |
| Drug | V11294 Analogue 5m | 9.86e-06 | 2 | 72 | 2 | CID011477773 | |
| Drug | (S)-Rolipram | 9.86e-06 | 2 | 72 | 2 | DB03606 | |
| Drug | 1-((5-(1-aminoethyl)-2-(8-methoxy-2-(triflurormethyl)-5-quinolinyl)-4-oxazolyl) carbonyl)-4-((cyclopropylcarbonyl)amino)proline ethyl ester | 9.86e-06 | 2 | 72 | 2 | ctd:C554440 | |
| Drug | V11294 Analogue 8a | 9.86e-06 | 2 | 72 | 2 | CID011442865 | |
| Drug | V11294 Analogue 5r | 9.86e-06 | 2 | 72 | 2 | CID011168555 | |
| Drug | V11294 Analogue 5j | 9.86e-06 | 2 | 72 | 2 | CID011433797 | |
| Drug | V11294 Analogue 5q | 9.86e-06 | 2 | 72 | 2 | CID011318772 | |
| Drug | V11294 Analogue 5a | 9.86e-06 | 2 | 72 | 2 | CID011386897 | |
| Drug | V11294 Analogue 5k | 9.86e-06 | 2 | 72 | 2 | CID011456440 | |
| Drug | V11294 Analogue 5h | 9.86e-06 | 2 | 72 | 2 | CID011306698 | |
| Drug | 3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester | 9.86e-06 | 2 | 72 | 2 | DB01959 | |
| Drug | 4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]-2-Pyrrolidinone | 9.86e-06 | 2 | 72 | 2 | DB01954 | |
| Drug | (R)-Rolipram | 9.86e-06 | 2 | 72 | 2 | DB04149 | |
| Drug | (4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one | 9.86e-06 | 2 | 72 | 2 | DB06842 | |
| Drug | imidazole | 1.15e-05 | 242 | 72 | 7 | CID000000795 | |
| Drug | CDP840 | 1.65e-05 | 16 | 72 | 3 | CID000127928 | |
| Drug | AC1LD7MJ | 1.75e-05 | 49 | 72 | 4 | CID000643628 | |
| Drug | Org 4428 | 2.95e-05 | 3 | 72 | 2 | CID000166560 | |
| Drug | 1-Pyrrolidinebutanenitrile | 2.95e-05 | 3 | 72 | 2 | CID000118838 | |
| Drug | BW A78U | 2.95e-05 | 3 | 72 | 2 | CID000127779 | |
| Drug | Enprofylline | 2.95e-05 | 3 | 72 | 2 | DB00824 | |
| Drug | diquafosol | 3.33e-05 | 20 | 72 | 3 | CID000148196 | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; HL60; HT_HG-U133A | 3.37e-05 | 193 | 72 | 6 | 2366_DN | |
| Drug | trequinsin | 3.43e-05 | 58 | 72 | 4 | CID000005537 | |
| Drug | PF-00539758-00 [351321-34-1]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.67e-05 | 196 | 72 | 6 | 6416_UP | |
| Drug | Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 3.89e-05 | 198 | 72 | 6 | 4392_UP | |
| Drug | Natamycin [7681-93-8]; Down 200; 6uM; HL60; HT_HG-U133A | 4.00e-05 | 199 | 72 | 6 | 6126_DN | |
| Drug | Tolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; PC3; HT_HG-U133A | 4.00e-05 | 199 | 72 | 6 | 4262_UP | |
| Drug | roflumilast | 4.46e-05 | 62 | 72 | 4 | CID000449193 | |
| Drug | siguazodan | 4.47e-05 | 22 | 72 | 3 | CID000072124 | |
| Drug | vanadyl | 5.27e-05 | 307 | 72 | 7 | CID000061671 | |
| Drug | denbufylline | 5.85e-05 | 24 | 72 | 3 | CID000002984 | |
| Drug | Caffeine | 5.89e-05 | 4 | 72 | 2 | DB00201 | |
| Drug | orthovanadate | 6.84e-05 | 435 | 72 | 8 | CID000061672 | |
| Drug | zaprinast | 8.51e-05 | 141 | 72 | 5 | CID000005722 | |
| Drug | AC1O3R20 | 9.39e-05 | 28 | 72 | 3 | CID006335051 | |
| Drug | Gonadotropins | 9.80e-05 | 5 | 72 | 2 | ctd:D006062 | |
| Drug | JM221 | 9.80e-05 | 5 | 72 | 2 | CID000148147 | |
| Drug | salbutamol | 1.00e-04 | 146 | 72 | 5 | CID000002083 | |
| Drug | motapizone | 1.04e-04 | 29 | 72 | 3 | CID000065819 | |
| Drug | NSC18930 | 1.04e-04 | 77 | 72 | 4 | CID000001189 | |
| Drug | DTIC | 1.27e-04 | 81 | 72 | 4 | CID005281007 | |
| Drug | AC1L73CW | 1.47e-04 | 84 | 72 | 4 | CID000328776 | |
| Drug | talniflumate | 1.47e-04 | 6 | 72 | 2 | CID000048229 | |
| Drug | 4-methylumbelliferyl phenylphosphonate | 1.47e-04 | 6 | 72 | 2 | CID000134928 | |
| Drug | Pentoxifylline | 1.47e-04 | 6 | 72 | 2 | DB00806 | |
| Drug | ibudilast | 1.55e-04 | 33 | 72 | 3 | CID000003671 | |
| Drug | IBMX | 1.63e-04 | 368 | 72 | 7 | CID000003758 | |
| Drug | zardaverine | 1.85e-04 | 35 | 72 | 3 | CID000005723 | |
| Drug | P-NE | 1.99e-04 | 169 | 72 | 5 | CID000446755 | |
| Drug | Theophylline | 2.05e-04 | 7 | 72 | 2 | DB00277 | |
| Drug | nitraquazone | 2.05e-04 | 7 | 72 | 2 | CID000068765 | |
| Drug | sildenafil | 2.45e-04 | 96 | 72 | 4 | CID000005212 | |
| Drug | RP 73401 | 2.55e-04 | 39 | 72 | 3 | CID000154575 | |
| Disease | specific developmental disorder (implicated_via_orthology) | 3.22e-05 | 4 | 69 | 2 | DOID:0060038 (implicated_via_orthology) | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 1.05e-04 | 39 | 69 | 3 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | Parkinson disease, late-onset | 2.40e-04 | 10 | 69 | 2 | cv:C3160718 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 2.40e-04 | 10 | 69 | 2 | 168600 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 3.50e-04 | 12 | 69 | 2 | C3160718 | |
| Disease | cystic fibrosis (is_marker_for) | 4.19e-04 | 62 | 69 | 3 | DOID:1485 (is_marker_for) | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 4.82e-04 | 14 | 69 | 2 | DOID:9743 (implicated_via_orthology) | |
| Disease | asthma (is_implicated_in) | 5.10e-04 | 157 | 69 | 4 | DOID:2841 (is_implicated_in) | |
| Disease | Asthma | 8.84e-04 | 80 | 69 | 3 | C0004096 | |
| Disease | irritability measurement | 9.50e-04 | 82 | 69 | 3 | EFO_0009594 | |
| Disease | snoring measurement | 1.02e-03 | 84 | 69 | 3 | EFO_0008341 | |
| Disease | physical activity | 1.16e-03 | 88 | 69 | 3 | EFO_0003940 | |
| Disease | blood pressure | 1.21e-03 | 22 | 69 | 2 | EFO_0004325 | |
| Disease | Parkinson disease | 1.21e-03 | 22 | 69 | 2 | cv:C0030567 | |
| Disease | Brugada Syndrome (disorder) | 1.44e-03 | 24 | 69 | 2 | C1142166 | |
| Disease | smoking status measurement | 1.48e-03 | 1160 | 69 | 9 | EFO_0006527 | |
| Disease | blood rubidium measurement | 1.69e-03 | 26 | 69 | 2 | EFO_0021529 | |
| Disease | neurotic disorder | 1.73e-03 | 101 | 69 | 3 | EFO_0004257 | |
| Disease | Developmental Academic Disorder | 2.10e-03 | 29 | 69 | 2 | C1330966 | |
| Disease | Learning Disorders | 2.10e-03 | 29 | 69 | 2 | C0023186 | |
| Disease | Learning Disturbance | 2.10e-03 | 29 | 69 | 2 | C0751263 | |
| Disease | Adult Learning Disorders | 2.10e-03 | 29 | 69 | 2 | C0751262 | |
| Disease | Learning Disabilities | 2.10e-03 | 29 | 69 | 2 | C0751265 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLHKNLQEHFSNQDL | 116 | Q6UWZ7 | |
| EHQDLGLYHLKQINS | 766 | Q13075 | |
| LHAKLKHLQDDNNLL | 771 | Q7Z7A1 | |
| QLENHELQGLKLQHD | 1706 | Q7Z7A1 | |
| DHQLIQEALIFDNKH | 691 | P12814 | |
| EKQHLRIQHLQSQFG | 131 | Q9BY76 | |
| RIQHLQSQFGLLDHK | 136 | Q9BY76 | |
| NNLNKFDEGLALAHF | 186 | P13569 | |
| LQHDVAHLFIKDTQG | 291 | O43506 | |
| QQDLKADHDALLFHL | 136 | P07307 | |
| NHNHHLILAGRQKEL | 746 | Q8IYW2 | |
| KGLFQALDENLHQLH | 4126 | Q86UQ4 | |
| KDLHFLEELQLGHNR | 311 | P35858 | |
| GLTAAKNLHHNLLNK | 1061 | O60706 | |
| HLFFLIGDKQAHKQL | 3011 | Q96M86 | |
| LAHHFLALGENDKAL | 1071 | Q96PN6 | |
| QGHDKDLQLHQSQLE | 296 | Q6ZP65 | |
| LLESGLVHFNENHIK | 801 | Q14004 | |
| DLVNLSHLFLHGNKL | 171 | Q86UN2 | |
| LHLELEALNGKHQQI | 491 | Q9NZM3 | |
| FDNVLNHLNDGKHEL | 1101 | Q9HCL0 | |
| CKIQDLEHHLGLALN | 1026 | Q9Y3P9 | |
| AHHFGQEELQANLDL | 191 | Q9UGV2 | |
| IKNDHKNNERLLFHG | 546 | Q460N3 | |
| EHFLLHREGKFNNTL | 56 | P43632 | |
| LAEENGKLVGHQNLH | 1336 | Q9NS87 | |
| VLENHHLAVGFKLLQ | 501 | P27815 | |
| ENHHLAVGFKLLQEE | 476 | Q07343 | |
| VLENHHLAVGFKLLQ | 456 | Q08493 | |
| LENHHLAVGFKLLQE | 531 | Q08499 | |
| GQFLKHLNNEHALDD | 361 | O15409 | |
| ILDDHKIQHLRLQGQ | 416 | Q9NUL7 | |
| NQLLADFHHIGSIKV | 196 | Q6UWN0 | |
| EHIHGLDKLQLAQFT | 201 | O14764 | |
| LGQFIKHLNTEHALD | 321 | Q8IVH2 | |
| DHQALLKQFDHLNHL | 131 | P80303 | |
| LKQFDHLNHLNPDKF | 136 | P80303 | |
| HLNLLKQFEHLDPQN | 131 | Q02818 | |
| GVEHQQLLDLAQKHL | 236 | P31930 | |
| LLHKVQHDLNSGVFN | 721 | Q9Y3Q4 | |
| NNLKHLILSHNDLEN | 276 | Q7Z2Q7 | |
| HKLEGALLALGQFQH | 6216 | Q9UPN3 | |
| NHLGHFLLTNLLLDK | 146 | Q8NBN7 | |
| QVLLGHIQKHNLTLF | 556 | Q9UFP1 | |
| EKCLNNQQLHFLHIG | 821 | P13671 | |
| DNHKALLVGEHLNII | 471 | P01031 | |
| HFLKLLVNLADHNGN | 811 | Q5T7N3 | |
| QKLQHLAVVLLGNEH | 191 | Q9Y2B1 | |
| EFLHNNLHLQGKVEG | 3551 | P21817 | |
| LAHLLVEDKGQNLHQ | 456 | Q5VW36 | |
| ELHNQLFEHQKEGIA | 91 | Q2NKX8 | |
| EDKGLLIQDAHFHQL | 116 | Q969Z0 | |
| HAFAGLKNLLRLHLN | 161 | Q6UXK5 | |
| LKFNLLAHLADDLGH | 96 | Q8N5N7 | |
| HLDLSQNLLQHKNDE | 401 | Q9BXR5 | |
| SNLDAEILQDHHKQL | 8581 | Q8NF91 | |
| QLLNEHLLGHLEQAK | 576 | P57071 | |
| DKLHGCLEHLFNQVD | 1216 | Q8TCU6 | |
| NLDKIHDENGNNLLH | 341 | Q9Y6H5 | |
| ALHLLANEQLEKGHI | 971 | P63128 | |
| AKNVFLHLHNLDLGF | 226 | O75027 | |
| LNKQQASFLHLALHN | 576 | O75762 | |
| LQKDLDDNLFGQHLA | 61 | O14656 | |
| GKEHAVIILNHNFEI | 86 | Q9NRZ7 | |
| ELSGHINLFVDVNKH | 806 | Q9H5L6 | |
| DLQLHVKHNHLENQG | 766 | Q96K83 | |
| ELLKHQLLGDLHQEG | 186 | P10636 | |
| QHLLFRGQLLEDDKH | 41 | Q8N7F7 | |
| DNLHNRKKHLNGLQH | 16 | Q9UDW3 | |
| DSEQNLFLHIKGQHE | 1496 | Q9C0G0 | |
| LEQLEHLDFQHSNLK | 421 | O00206 | |
| SQNHGDHLVLLKDEL | 11 | Q9BVV6 | |
| NNLLGIHHKILNEQI | 176 | Q6ZS27 | |
| GHQLQHDLFFDTLKI | 426 | P23378 | |
| NALSHNHNVKILDLG | 946 | Q86W25 | |
| SLDEFEANKILHQHL | 1706 | Q9NZM1 |